Filensin Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Filensin antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityFilensin
Clone[FIL-27]
Host SpeciesMouse
Reactive Specieshuman, bovine
IsotypeIgG1
Formatascites
Size0.1 mg
Concentrationn/a
ApplicationsWestern Blot (WB), Immunohistochemistry (IHC) Formalin
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionDescription: Mouse IgG monoclonal antibody for Filensin, beaded filament structural protein 1, filensin (BFSP1) detection. Tested with WB, IHC-F in Human. No cross reactivity with other proteins. Uniprot ID: Q12934 Background: Filensin, also known as beaded filament structure protein 1, have two major component BFSP1 and BESP2. Filensin gene is mapped at 20p12.1-p11.23. The sequence of the predicted 665-amino acid human protein is 62% and 50% identical to those of bovine and chicken filensin, respectively. However, it has less than 26% identity to other members of the intermediate filament(IF) family.
ImmunogenImmunogen: Human and bovine lens filament enriched fraction (plasma membrane-cytoskeleton complex).
Other Names[Filensin; beaded filament structural protein 1, filensin; CP115; CP94; CP115; LIFL-H; LIFL-H CYTOSKELETAL PROTEIN, 115-KD; Beaded filament structural protein 1; Lens fiber cell beaded-filament structural protein CP 115; Lens intermediate filament-like heavy], [BFSP1; BFSP1; CP94; CP115; LIFL-H; CTRCT33; CP115; LIFL-H]
Gene, Accession #[BFSP1], Gene ID: 631, NCBI: Q12934.3, UniProt: Q12934
Catalog #MBS175090
Price$315
Order / More InfoFilensin Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.